- Home
- SRRK vs CRNX Comparison
SRRK vs CRNX Comparison
Compare SRRK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- CRNX
- Stock Information
- Founded
- SRRK 2012
- CRNX 2008
- Country
- SRRK United States
- CRNX United States
- Employees
- SRRK N/A
- CRNX N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- SRRK Health Care
- CRNX Health Care
- Exchange
- SRRK Nasdaq
- CRNX Nasdaq
- Market Cap
- SRRK 3.2B
- CRNX 2.8B
- IPO Year
- SRRK 2018
- CRNX 2018
- Fundamental
- Price
- SRRK $34.04
- CRNX $30.16
- Analyst Decision
- SRRK Strong Buy
- CRNX Strong Buy
- Analyst Count
- SRRK 6
- CRNX 10
- Target Price
- SRRK $42.17
- CRNX $75.00
- AVG Volume (30 Days)
- SRRK 1.3M
- CRNX 676.7K
- Earning Date
- SRRK 08-07-2025
- CRNX 08-07-2025
- Dividend Yield
- SRRK N/A
- CRNX N/A
- EPS Growth
- SRRK N/A
- CRNX N/A
- EPS
- SRRK N/A
- CRNX N/A
- Revenue
- SRRK N/A
- CRNX $760,000.00
- Revenue This Year
- SRRK N/A
- CRNX $402.12
- Revenue Next Year
- SRRK $502.60
- CRNX $770.88
- P/E Ratio
- SRRK N/A
- CRNX N/A
- Revenue Growth
- SRRK N/A
- CRNX N/A
- 52 Week Low
- SRRK $6.76
- CRNX $24.10
- 52 Week High
- SRRK $46.98
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- SRRK 55.54
- CRNX 41.11
- Support Level
- SRRK $30.97
- CRNX $32.05
- Resistance Level
- SRRK $37.00
- CRNX $31.56
- Average True Range (ATR)
- SRRK 2.05
- CRNX 1.08
- MACD
- SRRK 0.23
- CRNX -0.18
- Stochastic Oscillator
- SRRK 65.40
- CRNX 5.25
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.